Frequency of Insomnia and Daytime Sleepiness in Patients with Chronic Renal Disease of Tijuana

Research Article

J Fam Med. 2020; 7(4): 1205.

Frequency of Insomnia and Daytime Sleepiness in Patients with Chronic Renal Disease of Tijuana

Soto-Ibarra KG1*, Rojo-Jimenez AG2, Velazquez-Corona SS1, Flores-Escutia M1, Garcia-Linares NC1 and Flores-Escutia R3

1Department of Family Medicine, Family Medicine Unit #27 (IMSS), Baja California Delegation, Mexico

2Department of Internal Medicine, Regional General Hospital #1 (IMSS), Baja California Delegation, Mexico

3Department of Intensive Care, National Medical Center of the West (IMSS), Jalisco Delegation, Mexico

*Corresponding author: Soto-Ibarra Karelica Guadalupe, Department of Family Medicine, Family Medicine Unit #27 (IMSS), Baja California Delegation, Mexico

Received: February 23, 2020; Accepted: April 13, 2020; Published: April 20, 2020

Abstract

Background: The frequency of sleep disorders in patients with chronic kidney disease is 20-70%, it is more prevalent in this group of patients compared to the general population. In users of hemodialysis (renal replacement therapy), the presence of insomnia and daytime sleepiness has been demonstrated as the most frequent sleep disorders.

Objective: To determine the frequency of insomnia and daytime sleepiness in patients with chronic kidney disease (hemodialysis) in Tijuana.

Design and Setting: Descriptive cross-sectional study.

Methods: A census was carried out that included 75 patients with renal replacement therapy (hemodialysis) within the Tijuana Regional General Hospital #1 during May 2019. The Athens scale was applied to determine the presence of insomnia and Epworth scale for daytime sleepiness. In the statistical analysis descriptive statistics were used with a 95% confidence interval.

Results: 55% of patients had insomnia and 25% daytime sleepiness.  

Conclusion: Insomnia was the most prevalent sleep disorder in our study, these results show the need to assess the quality of sleep and the actions to improve it as the main treatment for both conditions.

Keywords: Insomnia; Daytime Sleepiness; Chronic Kidney Disease

Introduction

Sleep disorders are a series of alterations related to the sleep process. There are sleep disorders at the beginning, maintenance and during the sleep-wake cycle. The sleep of the human being, according to polysomnographic criteria, is divided into REM (Rapid Eye Movement) and Non-REM (Non Rapid Eye Movement) sleep; both types of sleep are repeated in four or five cycles per night at intervals of 90-120 minutes [1]. Within these diseases is insomnia, which is defined as the difficulty in starting or maintaining sleep or feeling of not having had a satisfactory sleep. Daytime sleepiness characterized by the presence of excessive sleep during the day or difficulty staying alert and awake. The frequency of sleep disorders in patients with chronic kidney disease is 20-70% [2], it is more prevalent in this type of patients compared to the general population where insomnia is reported in 35% and daytime sleepiness 16% [3]. Currently, there is no information in Mexico that gives us an overview on this topic.

The consequences of lack of sleep affect the quality of life of patients, who have inability to concentrate, memory problems, deficits in neuropsychological tests and can generate fatal accidents due to drowsiness [4]. Sleep disorders do not always produce important manifestations in health, sometimes can be subtle symptoms such as emotional lability, irritability, low tolerance to frustration, behavior disorders and aggression, sleep disorders affect daytime functioning [5]. According to International Classification of Sleep Disorders (ICSD-3), more than 90 sleep disorders have been described, some of them have a high prevalence in the general population such as insufficient sleep syndrome (40%), insomnia (20%), respiratory disorders during sleep (2 -5%), restless leg syndrome (2%), periodic leg movements (MPP) during sleep, phase lag and parasomnias. Sleep disorders have been linked to an increase in mortality, cardiovascular diseases, accidents at work, traffic accidents, psychiatric disorders and deficiencies in the cognitive and performance area [6]. The objective of our research was to determine the frequency of insomnia and daytime sleepiness in patients with chronic kidney disease on hemodialysis of the General Regional Hospital # 1 of Tijuana.

Methods

Study design and population

A descriptive cross-sectional study was conducted in May 2019. The research was carried out in HGR #1 of the Instituto Mexicano del Seguro Social (IMSS); which has an area of hemodialysis. A census included 75 patients receiving renal replacement therapy (hemodialysis) and who agreed to participate in the study by signing the informed consent over 18 years.

Variables

The collection of variables was done with a standardized data sheet; the variables collected were the following: age, which was collected directly from the patients and their medical card; gender was through phenotypic characteristics; marital status, where it was classified as with or without a partner; the occupation was classified as unemployed or laborly active; the diagnosis of insomnia was made when applying the Athens scale, it is considered positive if a score greater than or equal to 6 points and for diagnosis of daytime sleepiness in case of obtaining a score greater than or equal to 9 on the Epworth scale; both questionnaires validated in Spanish, adapted to the Mexican population and with a Cronbach's alpha of 0.89 [7,8].

Citation:Soto-Ibarra KG, Rojo-Jimenez AG, Velazquez-Corona SS, Flores-Escutia M, Garcia-Linares NC and Flores-Escutia R. Frequency of Insomnia and Daytime Sleepiness in Patients with Chronic Renal Disease of Tijuana. J Fam Med. 2020; 7(4): 1205.